| 1 |
Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells[J]. Cell Tissue Kinet, 1970, 3(4):393-403.
|
| 2 |
Gruber HE, Deepe R, Hoelscher GL, et al. Human adipose-derived mesenchymal stem cells: direction to a phenotype sharing similarities with the disc, gene expression profiling, and coculture with human annulus cells[J]. Tissue Eng Part A, 2010, 16(9):2843-2860.
|
| 3 |
Patel J, Shafiee A, Wang W, et al. Novel isolation strategy to deliver pure fetal-origin and maternal-origin mesenchymal stem cell (MSC) populations from human term placenta[J]. Placenta, 2014, 35(11):969-971.
|
| 4 |
Li W, Ye B, Cai XY, et al. Differentiation of human umbilical cord mesenchymal stem cells into prostate-like epithelial cells in vivo[J]. PLoS One, 2014, 9(7):e102657.
|
| 5 |
Ponnaiyan D, Bhat KM, Bhat GS. Comparison of immuno-phenotypes of stem cells from human dental pulp and periodontal ligament[J]. Int J Immunopathol Pharmacol, 2012, 25(1):127-134.
|
| 6 |
Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood[J]. Br J Haematol, 2000, 109(1):235-242.
|
| 7 |
Ledesma-Martínez E, Mendoza-Núñez VM, Santiago-Osorio E. Mesenchymal stem cells for periodontal tissue regeneration in elderly patients[J]. J Gerontol A Biol Sci Med Sci, 2018. doi: 10.1093/gerona/gly227. [Epub ahead of print]. |
| 8 |
Rohringer S, Hofbauer P, Schneider KH, et al. Mechanisms of vasculogenesis in 3D fibrin matrices mediated by the interaction of adipose-derived stem cells and endothelial cells[J]. Angiogenesis, 2014, 17(4):921-933.
|
| 9 |
Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement[J]. Cytotherapy, 2006, 8(4):315-317.
|
| 10 |
Krampera M, Galipeau J, Shi Y, et al. Immunological characterization of multipotent mesenchymal stromal cells--The International Society for Cellular Therapy (ISCT) working proposal[J]. Cytotherapy, 2013, 15(9):1054-1061.
|
| 11 |
Reilkoff RA, Bucala R, Herzog EL. Fibrocytes: emerging effector cells in chronic inflammation[J]. Nat Rev Immunol, 2011, 11(6):427-435.
|
| 12 |
Lysy PA, Smets F, Sibille C, et al. Human skin fibroblasts: From mesodermal to hepatocyte-like differentiation[J]. Hepatology, 2007, 46(5):1574-1585.
|
| 13 |
Haniffa MA, Wang XN, Holtick U, et al. Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells[J]. J Immunol, 2007, 179(3):1595-1604.
|
| 14 |
Hamano S, Tomokiyo A, Hasegawa D, et al. Extracellular matrix from periodontal ligament cells could induce the differentiation of induced pluripotent stem cells to periodontal ligament stem Cell-Like cells[J]. Stem Cells Dev, 2018, 27(2):100-111.
|
| 15 |
Steingen C, Brenig F, Baumgartner L, et al. Characterization of key mechanisms in transmigration and invasion of mesenchymal stem cells[J]. J Mol Cell Cardiol, 2008, 44(6):1072-1084.
|
| 16 |
Wen S, Niu Y, Yeh S, et al. BM-MSCs promote prostate cancer progression via the conversion of normal fibroblasts to cancer-associated fibroblasts[J]. Int J Oncol, 2015, 47(2):719-727.
|
| 17 |
Linard C, Brachet M, Strup-Perrot C, et al. Autologous bone marrow mesenchymal stem cells improve the quality and stability of vascularized flap surgery of irradiated skin in Pigs[J]. Stem Cells Transl Med, 2018, 7(8):569-582.
|
| 18 |
方利君, 付小兵, 孙同柱, 等. 在体诱导骨髓间充质干细胞分化为表皮细胞的初步观察[J]. 中华创伤杂志, 2003, 19(4):19-21.
|
| 19 |
袁艳鹏, 王淑艳, 唐玺和, 等. 临床级脐带间充质干细胞鉴定及方法研究[J/CD]. 中华细胞与干细胞杂志:电子版, 2017, 7(2):65-70.
|
| 20 |
Alt EU, Senst C, Murthy SN, et al. Aging alters tissue resident mesenchymal stem cell properties[J]. Stem Cell Res, 2012, 8(2):215-225.
|
| 21 |
Majore I, Moretti P, Hass R, et al. Identification of subpopulations in mesenchymal stem cell-like cultures from human umbilical cord[J]. Cell Commun Signal, 2009, 7:6.
|
| 22 |
Hellström I, Horn D, Linsley P, et al. Monoclonal mouse antibodies raised against human lung carcinoma[J]. Cancer Res, 1986, 46(8):3917-3923.
|
| 23 |
Marken JS, Schieven GL, Hellström I, et al. Cloning and expression of the tumor-associated antigen L6[J]. Proc Natl Acad Sci U S A, 1992, 89(8):3503-3507.
|
| 24 |
Lin CI, Merley A, Sciuto TE, et al. TM4SF1:a new vascular therapeutic target in cancer[J]. Angiogenesis, 2014, 17(4):897-907.
|
| 25 |
Xue L, Yu X, Jiang X, et al. TM4SF1 promotes the self-renewal of esophageal cancer stem-like cells and is regulated by miR-141[J]. Oncotarget, 2017, 8(12):19274-19284.
|
| 26 |
Bae S, Shim SH, Park CW, et al. Combined omics analysis identifies transmembrane 4 L6 family member 1 as a surface protein marker specific to human mesenchymal stem cells[J]. Stem Cells Dev, 2011, 20(2):197-203.
|
| 27 |
Huang YK, Fan XG, Qiu F, et al. Genomics of hepatitis B virus-related hepatocellular carcinoma and adjacent noncancerous tissues with cDNA microarray[J]. Chin Med J (Engl), 2011, 124(13):2057-2064.
|
| 28 |
Xu J, Stolk JA, Zhang X, et al. Identification of differentially expressed genes in human prostate cancer using subtraction and microarray[J]. Cancer Res, 2000, 60(6):1677-1682.
|
| 29 |
Shih SC, Zukauskas A, Li D, et al. The L6 protein TM4SF1 is critical for endothelial cell function and tumor angiogenesis[J]. Cancer Res, 2009, 69(8):3272-3277.
|
| 30 |
Denardo SJ, O'Grady LF, Macey DJ, et al. Quantitative imaging of mouse L-6 monoclonal antibody in breast cancer patients to develop a therapeutic strategy[J]. Int J Rad Appl Instrum B, 1991, 18(6):621-631.
|
| 31 |
Chang YW, Chen SC, Cheng EC, et al. CD13 (aminopeptidase N) can associate with tumor-associated antigen L6 and enhance the motility of human lung cancer cells[J]. Int J Cancer, 2005, 116(2):243-252.
|
| 32 |
Cao J, Yang J, Ramachandran V, et al. TM4SF1 promotes gemcitabine resistance of pancreatic cancer in vitro and in vivo[J]. PLoS One, 2015, 10(12):e0144969.
|
| 33 |
Huang YK, Fan XG, Qiu F. TM4SF1 promotes proliferation, invasion, and metastasis in human liver cancer cells[J]. Int J Mol Sci, 2016, 17(5). pii: E661.
|
| 34 |
Visintin A, Knowlton K, Tyminski E, et al. Novel Anti-TM4SF1 Antibody-Drug conjugates with activity against tumor cells and tumor vasculature[J]. Mol Cancer Ther, 2015, 14(8):1868-1876.
|